CLEC12A and acute myeloid leukemia: Additionally, CLL-1 is not present in all AML patients; Haubner et al. found CLL-1 expression on LSC in 45% at diagnosis and 20% at relapse [28], while their later study found detectable levels in 60% of patients [29].